138 related articles for article (PubMed ID: 32632141)
21. BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells.
Ellmann L; Joshi MB; Resink TJ; Bosserhoff AK; Kuphal S
Lab Invest; 2012 Dec; 92(12):1788-800. PubMed ID: 23069940
[TBL] [Abstract][Full Text] [Related]
22. Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.
Boyle GM; Woods SL; Bonazzi VF; Stark MS; Hacker E; Aoude LG; Dutton-Regester K; Cook AL; Sturm RA; Hayward NK
Pigment Cell Melanoma Res; 2011 Jun; 24(3):525-37. PubMed ID: 21435193
[TBL] [Abstract][Full Text] [Related]
23. POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer.
Ishii J; Sato H; Sakaeda M; Shishido-Hara Y; Hiramatsu C; Kamma H; Shimoyamada H; Fujiwara M; Endo T; Aoki I; Yazawa T
Pathol Int; 2013 Mar; 63(3):158-68. PubMed ID: 23530560
[TBL] [Abstract][Full Text] [Related]
24. POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis.
Cook AL; Sturm RA
Pigment Cell Melanoma Res; 2008 Dec; 21(6):611-26. PubMed ID: 18983536
[TBL] [Abstract][Full Text] [Related]
25. The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.
Bishop JL; Thaper D; Vahid S; Davies A; Ketola K; Kuruma H; Jama R; Nip KM; Angeles A; Johnson F; Wyatt AW; Fazli L; Gleave ME; Lin D; Rubin MA; Collins CC; Wang Y; Beltran H; Zoubeidi A
Cancer Discov; 2017 Jan; 7(1):54-71. PubMed ID: 27784708
[TBL] [Abstract][Full Text] [Related]
26. NFATc2 is an intrinsic regulator of melanoma dedifferentiation.
Perotti V; Baldassari P; Molla A; Vegetti C; Bersani I; Maurichi A; Santinami M; Anichini A; Mortarini R
Oncogene; 2016 Jun; 35(22):2862-72. PubMed ID: 26387540
[TBL] [Abstract][Full Text] [Related]
27. Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination.
Pinner S; Jordan P; Sharrock K; Bazley L; Collinson L; Marais R; Bonvin E; Goding C; Sahai E
Cancer Res; 2009 Oct; 69(20):7969-77. PubMed ID: 19826052
[TBL] [Abstract][Full Text] [Related]
28. FAM188B Downregulation Sensitizes Lung Cancer Cells to Anoikis via EGFR Downregulation and Inhibits Tumor Metastasis In Vivo.
Jang EJ; Sung JY; Yoo HE; Jang H; Shim J; Oh ES; Goh SH; Kim YN
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33440835
[TBL] [Abstract][Full Text] [Related]
29. Human melanoblasts in culture: expression of BRN2 and synergistic regulation by fibroblast growth factor-2, stem cell factor, and endothelin-3.
Cook AL; Donatien PD; Smith AG; Murphy M; Jones MK; Herlyn M; Bennett DC; Leonard JH; Sturm RA
J Invest Dermatol; 2003 Nov; 121(5):1150-9. PubMed ID: 14708619
[TBL] [Abstract][Full Text] [Related]
30. Anoikis and metastatic potential of cloudman S91 melanoma cells.
Zhu Z; Sanchez-Sweatman O; Huang X; Wiltrout R; Khokha R; Zhao Q; Gorelik E
Cancer Res; 2001 Feb; 61(4):1707-16. PubMed ID: 11245487
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF.
Wellbrock C; Rana S; Paterson H; Pickersgill H; Brummelkamp T; Marais R
PLoS One; 2008 Jul; 3(7):e2734. PubMed ID: 18628967
[TBL] [Abstract][Full Text] [Related]
32. Neural lineage-specific homeoprotein BRN2 is directly involved in TTF1 expression in small-cell lung cancer.
Sakaeda M; Sato H; Ishii J; Miyata C; Kamma H; Shishido-Hara Y; Shimoyamada H; Fujiwara M; Endo T; Tanaka R; Kondo H; Goya T; Aoki I; Yazawa T
Lab Invest; 2013 Apr; 93(4):408-21. PubMed ID: 23358112
[TBL] [Abstract][Full Text] [Related]
33. Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling.
Foley JM; Scholten DJ; Monks NR; Cherba D; Monsma DJ; Davidson P; Dylewski D; Dykema K; Winn ME; Steensma MR
J Transl Med; 2015 Apr; 13():110. PubMed ID: 25889105
[TBL] [Abstract][Full Text] [Related]
34. Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim.
Yang JM; O'Neill P; Jin W; Foty R; Medina DJ; Xu Z; Lomas M; Arndt GM; Tang Y; Nakada M; Yan L; Hait WN
J Biol Chem; 2006 Apr; 281(14):9719-27. PubMed ID: 16443928
[TBL] [Abstract][Full Text] [Related]
35. STAT3 induces anoikis resistance, promotes cell invasion and metastatic potential in pancreatic cancer cells.
Fofaria NM; Srivastava SK
Carcinogenesis; 2015 Jan; 36(1):142-50. PubMed ID: 25411359
[TBL] [Abstract][Full Text] [Related]
36. Brn2 is a transcription factor regulating keratinocyte differentiation with a possible role in the pathogenesis of lichen planus.
Shi G; Sohn KC; Choi DK; Kim YJ; Kim SJ; Ou BS; Piao YJ; Lee YH; Yoon TJ; Lee Y; Seo YJ; Kim CD; Lee JH
PLoS One; 2010 Oct; 5(10):e13216. PubMed ID: 20967260
[TBL] [Abstract][Full Text] [Related]
37. Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells.
Azimi A; Tuominen R; Costa Svedman F; Caramuta S; Pernemalm M; Frostvik Stolt M; Kanter L; Kharaziha P; Lehtiö J; Hertzman Johansson C; Höiom V; Hansson J; Egyhazi Brage S
Cell Death Dis; 2017 Aug; 8(8):e3029. PubMed ID: 29048432
[TBL] [Abstract][Full Text] [Related]
38. HPW-RX40 restores anoikis sensitivity of human breast cancer cells by inhibiting integrin/FAK signaling.
Chen IH; Shih HC; Hsieh PW; Chang FR; Wu YC; Wu CC
Toxicol Appl Pharmacol; 2015 Dec; 289(2):330-40. PubMed ID: 26386190
[TBL] [Abstract][Full Text] [Related]
39. Adenoviral-mediated over-expression of Brn2 in the rat paraventricular nucleus: no effect on vasopressin or corticotrophin releasing factor RNA levels.
Wong LF; Murphy D
Mol Cell Endocrinol; 2003 Feb; 200(1-2):165-75. PubMed ID: 12644309
[TBL] [Abstract][Full Text] [Related]
40. Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF/NRAS mutation status.
Das I; Wilhelm M; Höiom V; Franco Marquez R; Costa Svedman F; Hansson J; Tuominen R; Egyhàzi Brage S
Cell Death Dis; 2019 Sep; 10(9):663. PubMed ID: 31506424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
